Fagron

We are very proud to have been a part of the USP Annual Compounding Implementation Workshop, organized by the United States Pharmacopeia. Being among the top industry experts in our field was a pleasure and an honor!

Bioidentical Hormone Replacement Therapy (BHRT) is always evolving, offering personalized solutions for unique patient needs. The Marion Gluck Training Academy is a renowned institution and the only dedicated academy in training health practitioners in the area of bio-identical hormone replacement therapy in the UK. Join their exclusive two-day course on prescribing BHRT, and take your expertise to the next level. You'll gain hands-on experience with Fagron’s high-quality bases and APIs, learning directly from industry leaders. 🗓️ When: 20 and 21 of September 📍 Where: Royal Society of Medicine Don’t miss this opportunity! More details on the post below.

5 more days to go! On September 10, Fagron Genomics is hosting a webinar on the genetic factors contributing to obesity and weight loss. Learn how NutriGen results can inform personalized nutrition and treatment strategies. You can learn more and subscribe here: https://lnkd.in/dcWDph7f

Exciting news! Fagron is now officially part of the #EuPFI consortium, working to develop better medicines for children. This collaboration is coordinated by University College London, and includes members from academia and industry. 📅 Mark your calendar: In September, the 16th Annual Conference of the European Paediatric Formulation Initiative will be held right here in Rotterdam, home to Fagron's global office. The event will bring together researchers, scientists, and students to share ideas and innovations in pediatric drug development. We’re honored to represent compounding medicine in this field and look forward to seeing you there!

If I were you, I wouldn’t miss this! Learn how your genes impact weight gain and obesity in our exclusive webinar on September 10, held by Fagron Genomics. The first 100 spots will get a special discount — so waste no time and register now! Details below 👇 https://lnkd.in/dcWDph7f

Brochure Update We're pleased to announce an update to the brochure for #Pigmerise™, Fagron's solution in the treatment of hypopigmentation disorders. The updated brochure includes the detailed mechanism of action, case studies, all the technical specifications, and step-by-step usage instructions. #Pigmerise™ is specifically designed for safe application on sensitive skin, difficult-to-treat areas, and is suitable for pediatric use. 👉 Download the updated brochure here: https://lnkd.in/dS4k7HPE

At Fagron, we're all about creating a cash-focused culture that sparks efficiency and innovation across our global teams. With Liudmila Gudina joining us as our Global Working Capital Manager, we're excited to share how we're taking a fresh, people-centered approach to managing working capital. Read the full article here: https://lnkd.in/eEagARcB

Fagron Delivers Strong H1 2024 Performance! 🚀 We're excited to share our impressive first-half results for 2024. Fagron achieved significant revenue and profitability growth, reflecting our strong execution and operational efficiencies. We've also made strategic investments to support our continued expansion: $39 million in Wichita and €15 million in FSS Netherlands. Our CEO, Rafael Padilla, highlighted our strong performance reflects execution and operational efficiencies, with significant growth across all regions, particularly in North America. We anticipate further revenue and profitability improvements for the full year. Watch the full presentation here: https://lnkd.in/eVh_Cbu5

As companies increasingly invest in holistic health, the demand for personalized healthcare solutions is set to rise significantly. Discover how Fagron Genomics US can help you deliver state-of-the-art wellness solutions to your corporate clients.

Register now for the Global Compounding Pharmacy Webinar! Expert pharmacists from South Africa, the USA, and the UK will be in a roundtable discussion. Great insights await :) Subscribe below!